CBPd-171 | Search

Skip to main content

MedPath Trial Home

Organizations News Research

Data Sources:ClinicalTrials.govEU CTRFDAEMANMPATGAHealth CanadaWHO ICTRP

MedPath Trial Home

Search trials. Track pipelines. Understand approvals. With AI-powered intelligence for clinical research.

Product

Clinical Trials
Drug Intelligence
Global Approvals
AI Research
Pricing

Resources

FAQ
Search

Company

News
About
Contact

Legal

Privacy Policy
Terms of Service

Disclaimer: This website provides information retrieval and data analysis services. The content does not constitute medical advice. Eligibility assessments are for reference only and should not replace consultation with qualified healthcare professionals. Data is sourced from public registries and regulatory agencies; MedPath does not guarantee completeness or accuracy. Always verify information with primary sources.

© 2026 MedPath Trial. All rights reserved.

We value your privacy

We use cookies to analyze site traffic and improve your experience. See our Privacy Policy.

9,228 results for “CBPd-171”

Trials

View all 6635 →

An Extension Study of JR-171-101 Study in Patients With Mucopolysaccharidosis Type I (MPS I)

14 participants · First posted Jul 1, 2020

Single and Multiple Ascending Dose Study of AMG 171 in Subjects With Obesity

60 participants · First posted Dec 13, 2019

Study of AHB-171 in Chronic Hepatitis B Participants

138 participants · First posted Jun 5, 2026

Drugs

View all 1842 →

CBPD-268

CBPD-409

BNT-171

Organizations

View all 10 →

HLB Pharmaceutical Co., Ltd.

South Korea

LILLY FRANCE

United States

BioAxone BioSciences, Inc.

United States

News

View all 741 →

Foghorn Therapeutics Secures $50 Million Financing to Advance First-in-Class Cancer Pipeline

Foghorn Therapeutics Advances Multi-Target Protein Degrader Pipeline with FHD-909 Phase 1 Trial Progressing

AusperBio Completes $120 Million Series C to Advance AHB-137 Toward Commercialization in Chronic Hepatitis B

Page 1 of 923